221
Participants
Start Date
July 31, 1994
Primary Completion Date
March 31, 2001
Study Completion Date
March 31, 2007
filgrastim
cyclophosphamide
cytarabine
daunorubicin hydrochloride
doxorubicin hydrochloride
etoposide
leucovorin calcium
methotrexate
pegaspargase
prednisone
thioguanine
vincristine sulfate
radiation therapy
Princess Margaret Hospital for Children, Perth
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York
Memorial Sloan-Kettering Cancer Center, New York
Herbert Irving Comprehensive Cancer Center, New York
Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
University of Iowa Hospitals and Clinics, Iowa City
University of Wisconsin Comprehensive Cancer Center, Madison
Mayo Clinic Cancer Center, Rochester
University of Chicago Cancer Research Center, Chicago
Children's Mercy Hospital, Kansas City
Children's Hospital of Denver, Denver
Huntsman Cancer Institute, Salt Lake City
Long Beach Memorial Medical Center, Long Beach
Children's Hospital of Orange County, Orange
Children's Hospital and Regional Medical Center - Seattle, Seattle
Children's Hospital Los Angeles, Los Angeles
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
UCSF Cancer Center and Cancer Research Institute, San Francisco
Children's National Medical Center, Washington D.C.
Indiana University Cancer Center, Indianapolis
University of Michigan Comprehensive Cancer Center, Ann Arbor
University of Nebraska Medical Center, Omaha
St. Joseph's Hospital and Medical Center, Paterson
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill
Children's Hospital Medical Center - Cincinnati, Cincinnati
Ireland Cancer Center, Cleveland
Children's Hospital of Columbus, Columbus
Doernbecher Children's Hospital, Portland
Vanderbilt Cancer Center, Nashville
University of Texas - MD Anderson Cancer Center, Houston
British Columbia Children's Hospital, Vancouver
IWK Grace Health Centre, Halifax
National Cancer Institute (NCI)
NIH
Children's Oncology Group
NETWORK